AllerGenis improves precision of food allergy diagnosis, assessment, and monitoring supported by Luminex xMAP® technology
Data-driven food allergy diagnostics company, AllerGenis, LLC announced on January 16 that it has entered into a non-exclusive agreement with Luminex Corporation (NASDAQ: LMNX). According to the terms, AllerGenis will have the rights to develop, market and sell its novel precision food allergy diagnostic assay using Luminex’s xMAP® Technology. The agreement supports the upcoming 2019 […]
